Abstract
Interleukin (IL)-2 is a pharmacologically important cytokine secreted by T-lymphocytes. Recombinant IL-2 (rIL-2) has been modified and produced in many systems. Mass production of rIL-2 is the prerequisite for its wide application. Using a site-directed mutagenesis strategy, we first generated a gene coding for a new type of mutant of human IL-2 (MhIL-2), in which we replaced the cysteine-125 in human IL-2 with alanine, the leucine-18 with methionine, and the leucine-19 with serine. Then we investigated the possibility of its production of MhIL-2 in a Pichia pastoris system. High-level secreted expression of MhIL-2 was achieved by methanol induction. When purified with ultrafiltration, cation-exchange chromatography, and Sephadex G100 gel filtration, about 100 mg of MhIL-2 with high purity was obtained from 1 L of ferment supernatant. Biologic activity assay revealed that the purified recombinant protein displayed increased activity on proliferation of IL-2-dependent CTLL-2 cells. These results suggest that MhIL-2 is an improved IL-2 mutant that might hold great promise for clinical use, and that P. pastoris is an excellent system for the mass production of biologically active hIL-2.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Morgan, D. A., Ruscetti, F. W., and Gallo, R. (1976), Science 193, 1007, 1008.
Henney, C. S., Kuribayashi, K., Kern, D. E., and Gillis, S. (1981), Nature 291, 335–338.
Ortaldo, J. R., Mason, A. T., Gerard, J. P., et al. (1984), J. Immunol. 133, 779–783.
Lindsey, K. R., Rosenberg, S. A., and Sherry, R. M. (2000), J. Clin. Oncol. 18, 1954–1959.
Davey, R. T., Murphy, R. L., Graziano, F. M., et al. (2000), J. Am. Med. Assoc. 284, 183–189.
Chun, T. W., Engel, D., Mizell, S. B., et al. (1999), Nat. Med. 5, 651–655.
Pardo, M., Castillo, I., Oliva, H., et al. (1997), Hepatology 26, 1318–1321.
Smith, K. A. (1988), Science 240, 1169–1176.
Ju, G., Collins, L., Kaffka, K. L., Tsien, W., and Simpson, R. (1987), J. Biol. Chem. 262, 5723–5731.
Wolfe, S. N., Dorin, G. J., Davis, J. T., Smith, F., Lim, A., and Weissburg, R. (1992), US Patent 5,162,507.
Rodríguez, A., Fernández, O., Guerra, M., et al. (2001), Biotechnol. Aplicada 18, 159–162.
Cereghino, J. L. and Cregg, J. M. (2000), FEMS Microbiol. Rev. 24, 45–66.
Gillis, S., Ferm, M. M., Ou, W., and Smith, K. A. (1978), J. Immunol. 120, 2027–2032.
Dariusz, S., Sarah, J., and Steer, R. H. (1993), J. Immunol. Methods 157, 203–207.
Sato, T., Matsui, H., Shibahara, S., et al. (1987), J. Biochem. 101, 525–534.
Fujimoto, S., Nakatsu, M., Kato, K., and Kitano, K. (1988), J. Ferment. Technol. 66, 181–185.
Saraswat, V., Lee, J., Kim, D. Y., and Park, Y. H. (2000), Biotechnol. Lett. 22, 261–265.
Ong, E., Alimonti, J. B., Greenwood, J. M., Miller, J. R. C., Warren, R. A. J., and Kilburn, D. G. (1995), Bioseparations 5, 95–104.
Magnuson, N. S., Linzmaier, P. M., Reeves, R., An, G., Hayglass, K., and Lee, J. M. (1998), Protein Express. Purif. 13, 45–52.
Park, Y. and Cheong, H. C. (2002), Protein Express. Purif. 25, 160–165.
Berndt, W. G., Chang, D. Z., Smith, K. A., and Ciardelli, T. L. (1994), Biochemistry 33, 6571–6577.
Fallon, E. M., Liparoto, S. F., Lee, K. J., Ciardelli, T. L., and Lauffenburger, D. A. (2000), J. Biol. Chem. 275, 6790–6797.
Scorer, C. A., Clare, J. J., McCombie, W. R., Romanos, M. A., and Sreekrishna, K. (1994), Biotechnology 12, 181–184.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, Y., Xiao, XY., Sun, M. et al. Expression and purification of a mutant of human interleukin-2 in Pichia pastoris . Appl Biochem Biotechnol 133, 77–86 (2006). https://doi.org/10.1385/ABAB:133:1:77
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ABAB:133:1:77